Stockscreener 앱 받기
27.07
1.89%
-0.5225
시장 영업 전:
27.03
-0.0375
-0.14%
전일 마감가:
$27.59
열려 있는:
$27
하루 거래량:
46,850
Relative Volume:
0.43
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-4.56%
1개월 성능:
+20.78%
6개월 성능:
+0.70%
1년 성능:
+37.61%
1일 변동 폭
$26.90
$27.54
1주일 범위
$26.90
$30.00
52주 변동 폭
$11.50
$34.28
Direxion Daily Lly Bull 2 X Etf Stock (ELIL) Company Profile
Compare ELIL vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELIL
Direxion Daily Lly Bull 2 X Etf
|
27.07 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
365.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
740.96 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
742.61 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
293.07 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
722.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Lly Bull 2 X Etf 주식(ELIL)의 최신 뉴스
Direxion Daily COIN Bull 2X ETF (CONX) Dividend History, Date, and Yield - CoinCodex
TSLA Stock Slips Overnight: SpaceX IPO Hype Is Starting To Look Like Amazon's Dot-Com Bubble Peak In 2000, Warns Ex-Lehman Trader - Stocktwits
Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q1 - Barchart
ETF Turns $100k to $1.28m in 1 Year. Reddit Says It’ll Double Again - Yahoo Finance
Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio. - Barchart.com
What Are the Best-Performing U.S. Leveraged ETFs Year-to-Date? Memory Chip Products Lead the Gains, Are They Worth Investing In? - TradingKey
3 Vanguard Dividend Funds for Low-Cost Income - Barchart.com
'No One Cares' – Over 20 Leveraged ETFs Shut Down In April, Including Crypto's LMBO And REKT - Stocktwits
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims - Barchart.com
Up 160% in One Month, This AI ETF Can Still 5X - 24/7 Wall St.
With Earnings Booming, Can Lilly Hold Its Pharma Crown? - Moomoo
GLP-1 Sales Continue to Lift Eli Lilly. Does That Make LLY Stock a Buy? - Barchart.com
Should You Buy the Dip in Eli Lilly Stock Today? - Barchart.com
Volatility Meets Earnings Season – Q1 2026 - Direxion
Asset Allocation Summit: Opportunities in Direxion’s Leveraged-Inverse Suite - Yahoo Finance
Eli Lilly (LLY): 3 Reasons We Love This Stock - Barchart.com
Top Performing Leveraged/Inverse ETFs: 04/12/2026 - Yahoo Finance
ELIL Options Volatility — NASDAQ:ELIL - TradingView
ELIL Options Chain — NASDAQ:ELIL - TradingView
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity (NYSEARCA:CURE) - Seeking Alpha
Eli Lilly Jumps 2.7% Amid Intraday Rally – What’s Driving the Surge? - Bitget
Eli Lilly Falls More Than 2.5%: What’s Causing This Significant Decline During Trading Hours? - Bitget
Direxion Daily LLY Bull 2X ETF (ELIL) Fundamental Analysis - Meyka
Stock List: Research Stocks from Around the World - GuruFocus
The Next Big AI Winner Might Not Be a Tech Company - Barchart.com
Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy? - Barchart.com
Eli Lilly Pops on GLP-1 Pill Approval. Should You Buy LLY Stock Here? - Barchart.com
Eli Lilly Surges 5.7% on FDA Approval of Foundayo – Can This Momentum Last? - bitget.com
"Direxion Daily LLY Bull 2X Shares declares quarterly distribution of $0.0922 - MSN
Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit? - Barchart.com
Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) Short Interest Up 52.0% in March - Defense World
Client First Investment Management Llc - MSN
Single Stocks Are Driving the Tape – Direxion Launches Four 2X Bull ETFs - Yahoo Finance
Want Income and Growth? This Simple 3-ETF Portfolio Does Both - Barchart.com
NVDL Surges 5.5% On Monday as NVIDIA and Semiconductor Stocks Rebound - 24/7 Wall St.
FEAC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Leveraged ETFs Are Designed to Be Aggressive and Speculative. That's Both the Appeal and the Risk. - AOL.com
Direxion Daily LLY Bull 2X Shares (NASDAQ:ELIL) Short Interest Down 72.6% in February - Defense World
The Buffett Multiplier: How to Get 2X Exposure to Berkshire Hathaway's Value Play - Yahoo Finance
Novo Nordisk Stock Is Deeply Oversold on Weight Loss Drug Fail. Should You Buy the Dip? - Barchart
ELIL | Direxion Daily LLY Bull Institutional Ownership - Quiver Quantitative
The 2x Leveraged SSO ETF Can Double Your Returns, Until Volatility Strikes - 24/7 Wall St.
What Are the Real Pros and Cons of Investing in Leveraged ETFs? - The Motley Fool
Think Twice Before Investing in Top 10 Best-Performing ETFs: What Makes Them a Risk - Yahoo Finance
Defiance Daily Target 2X Long ANET ETF (ANEL) Chart and Price History 2026 - MarketBeat
New Leveraged ETFs Are Just More ‘Bull Crap’ to Me. Here’s the Real Red Flag Investors Are Missing. - Yahoo Finance
Eli Lilly and Company (NYSE:LLY) Shares Gap Up Following Earnings Beat - Defense World
Eli Lilly Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Top Pharmaceutical Stocks To Research – January 30th - Defense World
Is This ETF Targeting Alphabet Stock a Buy After Oriental Harbor Added Shares to Its Position Worth $15.1 Million? - The Motley Fool
Direxion Daily Lly Bull 2 X Etf (ELIL) 재무 분석
Direxion Daily Lly Bull 2 X Etf (ELIL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.89%
자본화:
|
볼륨(24시간):